Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Spacer
Ipca Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524494 INE571A01038 314.5139046 IPCALAB 0.37 41,041.73 35.54 45.52 1
Your Result on : Markets | Equity | Corporate Information | Profit & Loss
     ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
INCOME :      
Sales Turnover 6677.926166.465814.625438.305139.164367.43
Excise Duty0.000.000.000.000.0029.61
Net Sales6677.926166.465814.625438.305139.164337.82
Other Income 71.29111.29111.1952.9262.2464.69
Stock Adjustments -128.4355.19-104.09126.00170.73155.05
Total Income6620.786332.945821.725617.225372.134557.56
EXPENDITURE :      
Raw Materials 1764.882033.571964.941911.881753.211635.75
Power & Fuel Cost235.60253.33277.21237.44201.48196.82
Employee Cost 1479.341336.191193.391102.14948.84870.79
Other Manufacturing Expenses 367.61356.81311.74279.03225.25198.30
Selling & Administrative Expenses 953.42846.95812.67612.89551.23523.99
Miscellaneous Expenses 503.13314.87236.31179.67113.31149.41
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure5303.985141.724796.264323.053793.323575.06
Operating Profit1316.801191.221025.461294.171578.81982.50
Interest 65.06122.5846.3410.4111.1318.84
Gross Profit1251.741068.64979.121283.761567.68963.66
Depreciation251.97246.48228.63209.65187.72178.69
Profit Before Tax999.77822.16750.491074.111379.96784.97
Tax340.90288.01223.95197.28244.98137.98
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax8.113.7420.8416.46-5.79-5.47
Reported Net Profit650.76530.41505.70860.371140.77652.46
Extraordinary Items -169.55-69.5217.517.868.3410.86
Adjusted Net Profit820.31599.93488.19852.511132.43641.60
Adjustment below Net Profit -4.92-1.39-2.051.15-0.16-107.04
P & L Balance brought forward4956.804478.524076.353316.312277.181752.53
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 101.4850.74101.48101.48101.4820.77
P & L Balance carried down5501.164956.804478.524076.353316.312277.18
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %400.00400.00400.00400.00400.00250.00
Dividend Per Share(Rs)4.004.004.004.008.005.00
Earnings Per Share-Unit Curr25.6520.9119.9333.9189.9351.64
Earnings Per Share(Adj)-Unit Curr25.6520.9119.9333.9144.9725.82
Book Value-Unit Curr271.64250.24231.66215.84374.67290.11
Book Value(Adj)-Unit Curr271.64250.24231.66215.84187.34145.06
Spacer